A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer (Q35229741)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer |
scientific article |
Statements
1 reference
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer (English)
1 reference
Rafal Dziadziuszko
1 reference
D Ross Camidge
1 reference
Marileila Varella-Garcia
1 reference
Paul A Bunn
1 reference
Wilbur A Franklin
1 reference
Fred R Hirsch
1 reference
Fairooz Kabbinavar
1 reference
Tim Eisen
1 reference
Renato Martins
1 reference
Fredrick M Schnell
1 reference
Katherine Richardson
1 reference
Frank Richardson
1 reference
Bret Wacker
1 reference
David W Sternberg
1 reference
Jason Rusk
1 reference
8 August 2011
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference